Literature DB >> 22544933

MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.

Yang Liu1, Lihua Lai, Qingyun Chen, Yinjing Song, Sheng Xu, Feng Ma, Xiaojian Wang, Jianli Wang, Hai Yu, Xuetao Cao, Qingqing Wang.   

Abstract

Myeloid-derived suppressor cells (MDSCs) potently suppress the anti-tumor immune responses and also orchestrate the tumor microenvironment that favors tumor angiogenesis and metastasis. The molecular networks regulating the accumulation and functions of tumor-expanded MDSCs are largely unknown. In this study, we identified microRNA-494 (miR-494), whose expression was dramatically induced by tumor-derived factors, as an essential player in regulating the accumulation and activity of MDSCs by targeting of phosphatase and tensin homolog (PTEN) and activation of the Akt pathway. TGF-β1 was found to be the main tumor-derived factor responsible for the upregulation of miR-494 in MDSCs. Expression of miR-494 not only enhanced CXCR4-mediated MDSC chemotaxis but also altered the intrinsic apoptotic/survival signal by targeting of PTEN, thus contributing to the accumulation of MDSCs in tumor tissues. Consequently, downregulation of PTEN resulted in increased activity of the Akt pathway and the subsequent upregulation of MMPs for facilitation of tumor cell invasion and metastasis. Knockdown of miR-494 significantly reversed the activity of MDSCs and inhibited the tumor growth and metastasis of 4T1 murine breast cancer in vivo. Collectively, our findings reveal that TGF-β1-induced miR-494 expression in MDSCs plays a critical role in the molecular events governing the accumulation and functions of tumor-expanded MDSCs and might be identified as a potential target in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544933     DOI: 10.4049/jimmunol.1103505

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  119 in total

1.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Authors:  Banumathy Gowrishankar; Ilsiya Ibragimova; Yan Zhou; Michael J Slifker; Karthik Devarajan; Tahseen Al-Saleem; Robert G Uzzo; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

Review 2.  In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

Authors:  Yunching Chen; Dong-Yu Gao; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2014-05-22       Impact factor: 15.470

3.  Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein α by microRNA-690.

Authors:  Venkatesh L Hegde; Sunil Tomar; Austin Jackson; Roshni Rao; Xiaoming Yang; Udai P Singh; Narendra P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

4.  Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.

Authors:  Alba Gonzalez-Junca; Kyla E Driscoll; Ilenia Pellicciotta; Shisuo Du; Chen Hao Lo; Ritu Roy; Renate Parry; Iliana Tenvooren; Diana M Marquez; Matthew H Spitzer; Mary Helen Barcellos-Hoff
Journal:  Cancer Immunol Res       Date:  2018-12-11       Impact factor: 11.151

Review 5.  Phenotype, development, and biological function of myeloid-derived suppressor cells.

Authors:  Yang Zhao; Tingting Wu; Steven Shao; Bingyi Shi; Yong Zhao
Journal:  Oncoimmunology       Date:  2015-10-14       Impact factor: 8.110

6.  Regulating Tumor Myeloid-Derived Suppressor Cells by MicroRNAs.

Authors:  Siqi Chen; Yi Zhang; Timothy M Kuzel; Bin Zhang
Journal:  Cancer Cell Microenviron       Date:  2015

7.  MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis.

Authors:  Clara McClure; Laura Brudecki; Donald A Ferguson; Zhi Q Yao; Jonathan P Moorman; Charles E McCall; Mohamed El Gazzar
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

Review 8.  MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.

Authors:  F J Kohlhapp; A K Mitra; E Lengyel; M E Peter
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

Review 9.  The immunobiology of myeloid-derived suppressor cells in cancer.

Authors:  Morteza Motallebnezhad; Farhad Jadidi-Niaragh; Elmira Safaie Qamsari; Salman Bagheri; Tohid Gharibi; Mehdi Yousefi
Journal:  Tumour Biol       Date:  2015-11-26

10.  NFI-A disrupts myeloid cell differentiation and maturation in septic mice.

Authors:  Clara McClure; Ekram Ali; Dima Youssef; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  J Leukoc Biol       Date:  2015-08-10       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.